Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by fasttrack5on Jul 26, 2018 7:01am

150 Views

Post# 28369267

On BNN This sat and sun

Theralase Technologies Inc.(TSXV: TLT) (OTCQX: TLTFF) — BTV reveals their innovative medical technology for bladder cancer treatment. See Feature

Including comments from Managing Director at GMP Securities L.P., Martin Landry. See Feature

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”